Recommended Products
Quality Level
Assay
≥98%
form
powder
reaction suitability
reagent type: catalyst
reagent type: ligand
reaction type: C-H Activation
mp
277-280 °C (lit.)
solubility
95% ethanol: soluble 50 mg/mL, clear to hazy, colorless to dark yellow
SMILES string
Cc1cnc2c(ccc3c(C)c(C)cnc23)c1C
InChI
1S/C16H16N2/c1-9-7-17-15-13(11(9)3)5-6-14-12(4)10(2)8-18-16(14)15/h5-8H,1-4H3
InChI key
NPAXPTHCUCUHPT-UHFFFAOYSA-N
General description
3,4,7,8-Tetramethyl-1,10-phenanthroline is a metal-chelating agent. It acts as ligand and forms dinuclear Cu(II) hypocrellin B complexes. It also forms tetraaqua(3,4,7,8-tetramethyl-1,10-phenanthroline-kappa2N,N′)zinc(II) thiosulfate complex with zinc.
Application
3,4,7,8-Tetramethyl-1,10-phenanthroline was used in the synthesis of heteroleptic cationic Ir(III) complex, 3,4,7,8-tetramethyl-1,10-phenanthroline-bis[2-(2′,4′-difluorophenyl)pyridine]iridium(III) hexafluorophosphate.
Storage Class Code
11 - Combustible Solids
WGK
WGK 3
Personal Protective Equipment
dust mask type N95 (US), Eyeshields, Gloves
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Customers Also Viewed
Origin of the large spectral shift in electroluminescence in a blue light emitting cationic iridium (III) complex.
Journal of Materials Chemistry, 17(48), 5032-5041 (2007)
Actions of an inert nickel (II) chelate of tetramethyl-1,10-phenanthroline at calcium-dependent sites on the guinea-pig isolated atrium.
Methods and findings in experimental and clinical pharmacology, 1(4), 239-260 (1979-10-01)
Inorganic chemistry, 48(8), 3438-3452 (2009-04-14)
Pentanuclear cyanide-bridged clusters of the general formula {[M(tmphen)(2)](3)[M'(CN)(6)](2)} (tmphen = 3,4,7,8-tetramethyl-1,10-phenanthroline) have been under investigation in our laboratories for a number of years. These related molecules are conveniently prepared by a building block approach that involves the reaction of mononuclear
Inorganic chemistry, 49(21), 10108-10116 (2010-09-30)
Five new dinuclear Cu(II) complexes were designed and synthesized, using hypocrellin B, a naturally occurring photosensitizer that has received extensive studies as promising photodynamic therapy (PDT) agent, as bridging ligand, and five kinds of diimine ligands, including 2,2'-bipyridine (bpy), 1,10-phenanthroline
Dalton transactions (Cambridge, England : 2003), 40(10), 2180-2189 (2010-08-19)
Four new luminescent cyclometallated iridium(III) bis(quinolylbenzaldehyde) diimine complexes [Ir(qba)(2)(N⁁N)](PF(6)) (Hqba = 4-(2-quinolyl)benzaldehyde, N⁁N = 2,2'-bipyridine, bpy (1); 1,10-phenanthroline, phen (2); 3,4,7,8-tetramethyl-1,10-phenanthroline, Me(4)-phen (3); 4,7-diphenyl-1,10-phenanthroline, Ph(2)-phen (4)) have been synthesised and characterised, and their electronic absorption, emission and electrochemical properties investigated.
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service